BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Abu-Hammad O, Alduraidi H, Abu-Hammad S, Alnazzawi A, Babkair H, Abu-Hammad A, Nourwali I, Qasem F, Dar-Odeh N. Side Effects Reported by Jordanian Healthcare Workers Who Received COVID-19 Vaccines. Vaccines (Basel) 2021;9:577. [PMID: 34205917 DOI: 10.3390/vaccines9060577] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Riad A, Hocková B, Kantorová L, Slávik R, Spurná L, Stebel A, Havriľak M, Klugar M. Side Effects of mRNA-Based COVID-19 Vaccine: Nationwide Phase IV Study among Healthcare Workers in Slovakia. Pharmaceuticals (Basel) 2021;14:873. [PMID: 34577573 DOI: 10.3390/ph14090873] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 16.0] [Reference Citation Analysis]
2 Park C, Sakong J, Jo S, Kim M, Baek K. Adverse Effects on Work and Daily Life Interference among Healthcare Workers after the First and Second ChAdOx1 and BNT162b2 COVID-19 Vaccine Doses. Vaccines (Basel) 2021;9:926. [PMID: 34452051 DOI: 10.3390/vaccines9080926] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Hamza MS, Tikamdas R, El Baghdady NS, Sayed M, Elbarazi AS, Badary OA, Elmazar MM. Safety and Effectiveness of COVID-19 Vaccines: Results from a Cross-Sectional Survey among Staff, Workers and Students at an Egyptian University. Vaccines (Basel) 2022;10:846. [PMID: 35746454 DOI: 10.3390/vaccines10060846] [Reference Citation Analysis]
4 Liu R, Pan J, Zhang C, Sun X. Cardiovascular Complications of COVID-19 Vaccines. Front Cardiovasc Med 2022;9:840929. [DOI: 10.3389/fcvm.2022.840929] [Reference Citation Analysis]
5 Dar-Odeh N, Abu-Hammad O, Qasem F, Jambi S, Alhodhodi A, Othman A, Abu-Hammad A, Al-Shorman H, Ryalat S, Abu-Hammad S. Long-term adverse events of three COVID-19 vaccines as reported by vaccinated physicians and dentists, a study from Jordan and Saudi Arabia. Hum Vaccin Immunother 2022;18:2039017. [PMID: 35240939 DOI: 10.1080/21645515.2022.2039017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Abu-Halaweh S, Alqassieh R, Suleiman A, Al-Sabbagh MQ, AbuHalaweh M, AlKhader D, Abu-Nejem R, Nabulsi R, Al-Tamimi M, Alwreikat M, Alnouti M, Suleiman B, Yousef M, Jarbeh ME, Al-Shudifat AE, Alqassieh A, Bsisu I. Qualitative Assessment of Early Adverse Effects of Pfizer-BioNTech and Sinopharm COVID-19 Vaccines by Telephone Interviews. Vaccines (Basel) 2021;9:950. [PMID: 34579187 DOI: 10.3390/vaccines9090950] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Riad A, Pokorná A, Klugarová J, Antalová N, Kantorová L, Koščík M, Klugar M. Side Effects of mRNA-Based COVID-19 Vaccines among Young Adults (18-30 Years Old): An Independent Post-Marketing Study. Pharmaceuticals (Basel) 2021;14:1049. [PMID: 34681273 DOI: 10.3390/ph14101049] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
8 Kandimalla R, Chakraborty P, Vallamkondu J, Chaudhary A, Samanta S, Reddy PH, De Feo V, Dewanjee S. Counting on COVID-19 Vaccine: Insights into the Current Strategies, Progress and Future Challenges. Biomedicines 2021;9:1740. [PMID: 34829969 DOI: 10.3390/biomedicines9111740] [Reference Citation Analysis]
9 Abdellatif AAH, Alsowinea AF. Approved and marketed nanoparticles for disease targeting and applications in COVID-19. Nanotechnology Reviews 2021;10:1941-77. [DOI: 10.1515/ntrev-2021-0115] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Al-Qerem W, Jarab A, Hammad A, Alsajri AH, Al-Hishma SW, Ling J, Alabdullah AS, Salama A, Mosleh R. Knowledge, Attitudes, and Practices of Adult Iraqi Population Towards COVID-19 Booster Dose: A Cross-Sectional Study. Patient Prefer Adherence 2022;16:1525-37. [PMID: 35769339 DOI: 10.2147/PPA.S370124] [Reference Citation Analysis]
11 Gopaul CD, Ventour D, Thomas D. ChAdOx1 nCoV-19 Vaccine Side Effects among Healthcare Workers in Trinidad and Tobago. Vaccines 2022;10:466. [DOI: 10.3390/vaccines10030466] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
12 Fiolet T, Kherabi Y, MacDonald CJ, Ghosn J, Peiffer-Smadja N. Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: A narrative review. Clin Microbiol Infect 2021:S1198-743X(21)00604-2. [PMID: 34715347 DOI: 10.1016/j.cmi.2021.10.005] [Cited by in Crossref: 100] [Cited by in F6Publishing: 63] [Article Influence: 100.0] [Reference Citation Analysis]
13 Etemadifar M, Abhari AP, Nouri H, Sigari AA, Piran Daliyeh SM, Maracy MR, Salari M, Maleki S, Sedaghat N. Self-Reported safety of the BBIBP-CorV (Sinopharm) COVID-19 vaccine among Iranian people with multiple sclerosis. Hum Vaccin Immunother 2022;18:2041945. [PMID: 35201963 DOI: 10.1080/21645515.2022.2041945] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Elgendy MO, El-gendy AO, Mahmoud S, Mohammed TY, Abdelrahim MEA, Sayed AM. Side Effects and Efficacy of COVID-19 Vaccines among the Egyptian Population. Vaccines 2022;10:109. [DOI: 10.3390/vaccines10010109] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
15 Klugar M, Riad A, Mekhemar M, Conrad J, Buchbender M, Howaldt HP, Attia S. Side Effects of mRNA-Based and Viral Vector-Based COVID-19 Vaccines among German Healthcare Workers. Biology (Basel) 2021;10:752. [PMID: 34439984 DOI: 10.3390/biology10080752] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 30.0] [Reference Citation Analysis]
16 Dziedzic A, Riad A, Attia S, Klugar M, Tanasiewicz M. Self-Reported Adverse Events of COVID-19 Vaccines in Polish Healthcare Workers and Medical Students. Cross-Sectional Study and Pooled Analysis of CoVaST Project Results in Central Europe. J Clin Med 2021;10:5338. [PMID: 34830620 DOI: 10.3390/jcm10225338] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
17 Solomon Y, Eshete T, Mekasha B, Assefa W. COVID-19 Vaccine: Side Effects After the First Dose of the Oxford AstraZeneca Vaccine Among Health Professionals in Low-Income Country: Ethiopia. J Multidiscip Healthc 2021;14:2577-85. [PMID: 34556992 DOI: 10.2147/JMDH.S331140] [Reference Citation Analysis]
18 Castaldo M, Waliszewska-prosół M, Koutsokera M, Robotti M, Straburzyński M, Apostolakopoulou L, Capizzi M, Çibuku O, Ambat FDF, Frattale I, Gadzhieva Z, Gallo E, Gryglas-dworak A, Halili G, Jusupova A, Koperskaya Y, Leheste A, Manzo ML, Marcinnò A, Marino A, Mikulenka P, Ong BE, Polat B, Popovic Z, Rivera-mancilla E, Roceanu AM, Rollo E, Romozzi M, Ruscitto C, Scotto di Clemente F, Strauss S, Taranta V, Terhart M, Tychenko I, Vigneri S, Misiak B, Martelletti P, Raggi A; On behalf of the European Headache Federation School of Advanced Studies (EHF-SAS). Headache onset after vaccination against SARS-CoV-2: a systematic literature review and meta-analysis. J Headache Pain 2022;23. [DOI: 10.1186/s10194-022-01400-4] [Reference Citation Analysis]
19 Dighriri IM, Alhusayni KM, Mobarki AY, Aljerary IS, Alqurashi KA, Aljuaid FA, Alamri KA, Mutwalli AA, Maashi NA, Aljohani AM, Alqarni AM, Alfaqih AE, Moazam SM, Almutairi MN, Almutairi AN. Pfizer-BioNTech COVID-19 Vaccine (BNT162b2) Side Effects: A Systematic Review. Cureus 2022;14:e23526. [PMID: 35494952 DOI: 10.7759/cureus.23526] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Muluneh AG, Merid MW, Gelaye KA, Tilahun SY, Teshager NW, Abereha AY, Sugamo KS, Yimer MA, Kassa GM. More Than Three-Fourths of AstraZeneca (ChAdox1 COV-19) COVID-19 Vaccinated Individuals Develop Post Immunization Adverse Event in Northwest Ethiopia. IDR 2022;Volume 15:2409-16. [DOI: 10.2147/idr.s360605] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Boshra MS, Hussein RRS, Mohsen M, Elberry AA, Altyar AE, Tammam M, Sarhan RM. A Battle against COVID-19: Vaccine Hesitancy and Awareness with a Comparative Study between Sinopharm and AstraZeneca. Vaccines 2022;10:292. [DOI: 10.3390/vaccines10020292] [Reference Citation Analysis]
22 Nassar RI, Alnatour D, Thiab S, Nassar A, El-Hajji F, Basheti IA. Short-term side effects of COVID-19 vaccines: A cross-sectional study in Jordan. Hum Vaccin Immunother 2022;:2082792. [PMID: 35759219 DOI: 10.1080/21645515.2022.2082792] [Reference Citation Analysis]
23 Lounis M, Rais MA, Bencherit D, Aouissi HA, Oudjedi A, Klugarová J, Pokorná A, Klugar M, Riad A. Side Effects of COVID-19 Inactivated Virus vs. Adenoviral Vector Vaccines: Experience of Algerian Healthcare Workers. Front Public Health 2022;10:896343. [PMID: 35651866 DOI: 10.3389/fpubh.2022.896343] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
24 Alagheband Bahrami A, Azargoonjahromi A, Sadraei S, Aarabi A, Payandeh Z, Rajabibazl M. An overview of current drugs and prophylactic vaccines for coronavirus disease 2019 (COVID-19). Cell Mol Biol Lett 2022;27:38. [PMID: 35562685 DOI: 10.1186/s11658-022-00339-3] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 Al-amer R, Malak MZ, Burqan HMR, Stănculescu E, Nalubega S, Alkhamees AA, Hendawy AO, Ali AM. Emotional Reaction to the First Dose of COVID-19 Vaccine: Postvaccination Decline in Anxiety and Stress among Anxious Individuals and Increase among Individuals with Normal Prevaccination Anxiety Levels. JPM 2022;12:912. [DOI: 10.3390/jpm12060912] [Reference Citation Analysis]